Stemcell Storage Banking

Listing ID #1502754

Get Latest Price

colourblue
colourblack
colourred
Business Type Service Provider

Preferred Buyer From : India only

Service Details

provide protection of your baby for lifetime with cord blood stem cell banking.
umbilical cord blood(UCB) is the blood that remains in the cord of the baby at the time of birth. cord blood is richest source of stem-cells which can be safely collected, processed and preserved for potential medical use in the future.
over 80 types of terminal blood disorder including leukaemia, thalsemia, sickle cell anaemia, myeloma and lymphoma are being currently treated across the worldwide cord blood stem-cell.
umbilical cord blood stem-cell banking is a means to safeguard and invest in your baby's and family's future health. cord blood cells are genetically unique and are a 100% match for the same child. the probability of a matches high for siblings and also be a match for other family members.
StemCyte India is the only cord blood bank in the country that is actively involved in 1)public bank: the UCB is donated to StemCyte for processing and storage for further therapeutic use by unrelated patients.
2) private banking: UCB is collected, processed and stored for the future medical needs of the child or the family.
3) advance therapeutics: treatment of patients in need.
4) clinical trials: use of cord blood stem cells in indications like spinal cord injuries, stroke etc.
StemCyte India facilitated as many 2000 transplant across 315 centres in 38 countries across 6 continents.

Company Details

StemCyte India Therapeutics Pvt. Ltd. (USA based company): World class stems cell banking.
It was born on the 1st Vibrant Gujarat Summit by Honorable Prime Minister Shri Narendrabhai Modi.
It was established in 2008 and it is a joint venture between StemCyte Inc. (USA), Apollo Hospital Enterprises Ltd. and Cadila Pharmaceuticals Ltd.
We have patented Plasma depletion technology design to deliver maximum number of high quality stem cell. Ensures cell recovery up to 99.96% - unmatched in industry.
StemCyte is the world leader in Umbilical cord blood transplant. It is the only company with the experience of treating 58 Hematopoetic blood disorders like Thelassemia, CGD, HLH, Fanconi Anemia, Immune Defiency Disorder and Infantile etc.
• We have facilitated as many as 2000 transplant across 315 centers in 38 countries across 6 continents.
• The company is backed by a world-class doctor fraternity within the Apollo group.
• We have 75,000 units in Public & Private inventories across the globe.
• StemCyte offers a complete stem cell solution from banking to application.
• We have a trained transplant coordination team, together with trained staff at all touch points, works to achieve best possible outcomes.
• International accreditation, FDA and AABB approved certifications and licenses that endorse commitment to quality.
• We adopt a unique “hybrid+” model involving public banking, private banking, therapeutic application and clinical trials.